Bridgebio Oncology Therapeutics, Inc. (BBOT)
4.71
-0.06
(-1.26%)
USD |
NASDAQ |
Sep 21, 11:10
Bridgebio Oncology Therapeutics Total Assets (Quarterly) : 376.71M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 376.71M |
| March 31, 2026 | 417.65M |
| December 31, 2025 | 449.08M |
| September 30, 2025 | 484.79M |
| June 30, 2025 | 197.39M |
| March 31, 2025 | 195.68M |
| Date | Value |
|---|---|
| December 31, 2024 | 164.31M |
| September 30, 2024 | 192.33M |
| June 30, 2024 | 189.87M |
| March 31, 2024 | 187.53M |
| December 31, 2023 | 0.3329M |
| December 31, 2022 | 0.1446M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 15.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 53.59M |
| Shareholders Equity (Quarterly) | 323.11M |
| Debt to Equity Ratio | 0.0078 |
| Current Ratio | 4.694 |
| Net Debt Paydown Yield | -0.08% |